Effects of continuous exposure to digoxin on MDR1 function and expression in Caco-2 cells

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 5, 2003, Pages 675-681

  Takara, Kohji ^a   Tsujimoto, Masayuki ^a   Ohnishi, Noriaki ^a   Yokoyama, Teruyoshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DIGOXIN; FLUOROURACIL; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; RHODAMINE 123;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL STRAIN CACO 2; CELL STRAIN CACO DX; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EXPOSURE; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; IC 50; INTESTINE MUCOSA PERMEABILITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRAIN DIFFERENCE;

CACO-2 CELLS; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GROWTH INHIBITORS; HUMANS; P-GLYCOPROTEIN; RNA, MESSENGER;

EID: 0037938688     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235703765344595     Document Type: Article

References (31)

1. Bates, S. E., Mickley, L. A., Chen, Y. N., Richert, N., Rudick, J., Biedler, J. L., Fojo, A. T. (1989) Expression of a drug resistance gene in human neuroblastoma cell lines: Modulation by retinoic acid-induced differentiation. Mol. Cell Biol. 9: 4337-4344
2. Borst, P., Schinkel, A. H., Smit, J. J., Wagenaar, E., Van Deemter, L., Smith, A. J., Eijdems, E. W., Baas, F., Zaman, G. J. (1993) Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol. Ther. 60: 289-299
3. Bradshaw, D. M., Arceci, R. J. (1998) Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J. Clin. Oncol. 16: 3674-3690
4. Brouillard, F., Tondelier, D., Edelman, A., Baudouin-Legros, M. (2001) Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells. Cancer Res. 61: 1693-1698
5. Chaudhary, P. M., Roninson, I. B. (1993) Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. 85: 632-639
6. Chin, K. V., Tanaka, S., Darlington, G., Pastan, I., Gottesman, M. M. (1990) Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265: 221-226
7. Giaccone, G., Van Ark-Otte, J., Rubio, G. J., Gazdar, A. F., Broxterman, H. J., Dingemans, A. M., Flens, M. J., Scheper, R. J., Pinedo, H. M. (1996) MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs. Int. J. Cancer 66: 760-767
8. Gottesman, M. M., Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62: 385-427
9. Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H. P., Von Richter, O., Zundler, J., Kroemer, H. K. (1999) The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J. Clin. Invest. 104: 147-153
10. Hipfner, D. R., Deeley, R. G., Cole, S. P. (1999) Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta 1461: 359-376
11. Hoffmeyer, S., Burk, O., Von Richter, O., Arnold, H. P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., Brinkmann, U. (2000) Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA 97: 3473-3478
12. Iida, N., Takara, K., Ohmoto, N., Nakamura, T., Kimura, T., Wada, A., Hirai, M., Sakaeda, T., Okumura, K. (2001) Reversal effects of antifungal drugs on multidrug resistance in MDR1-overexpressing HeLa cells. Biol. Pharm. Bull. 24: 1032-1036
13. Johansson, S., Lindholm, P., Gullbo, J., Larsson, R., Bohlin, L., Claeson, P. (2001) Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs 12: 475-483
14. Johne, A., Brockmoller, J., Bauer, S., Maurer, A., Langheinrich, M., Roots, I. (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St. John's worth (Hypericum perforatum). Clin. Pharmacol. Ther. 66: 338-345
15. Kim, S. H., Yeo, G. S., Lim, Y. S., Kang, C. D., Kim, C. M., Chung, B. S. (1998) Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells. Exp. Mol. Med. 30: 87-92
16. Kim, W. J., Kakehi, Y., Hirai, M., Arao, S., Hiai, H., Fukumoto, M., Yoshida, O. (1995) Multidrug resistance-associated protein-mediated multidrug resistance modulated by cyclosporin A in a human bladder cancer cell line. Jpn. J. Cancer Res. 86: 969-977
17. Kopnin, B. P., Sokova, O. I., Demidova, N. S. (1992) Regularities of karyotypic evolution during stepwise amplification of genes determining drug resistance. Mutat. Res. 276: 163-177
18. Kusuhara, H., Suzuki, H., Sugiyama, Y. (1998) The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs. J. Pharm. Sci. 87: 1025-1040
19. Leslie, E. M., Deeley, R. G., Cole, S. P. (2001) Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167: 3-23
20. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
21. Schinkel, A. H., Wagenaar, E., Mol, C. A., Van Deemter, L. (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97: 2517-2524
22. Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A., Van Deemter, L., Smit, J. J., Van Der Valk, M. A., Voordouw, A. C., Spits, H., Van Tellingen, O., Zijlmans, J. M., Fibbe, W. E., Borst, P. (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94: 4028-4033
23. Shen, D. W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., Gottesman, M. M. (1986) Human multidrug-resistant cell lines: Increased mdr1 expression can precede gene amplification. Science 232: 643-645
24. Synold, T. W., Dussault, I., Forman, B. M. (2001) The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. 7: 584-590
25. Takara, K., Sakaeda, T., Yagami, T., Kobayashi, H., Ohmoto, N., Horinouchi, M., Nishiguchi, K., Okumura, K. (2002a) Cytotoxic effects of 27 anticancer drugs in HeLa and MDR1-overexpressing derivative cell lines. Biol. Pharm. Bull. 25: 771-778
26. Takara, K., Tsujimoto, M., Ohnishi, N., Yokoyama, T. (2002b) Digoxin up-regulates MDR1 in human colon carcinoma Caco-2 cells. Biochem. Biophys. Res. Commun. 292: 190-194
27. Tanigawara, Y. (2000) Role of P-glycoprotein in drug disposition. Ther. Drug Monit. 22: 137-140
28. Tanigawara, Y.,Okamura, N., Hirai, M., Yasuhara, M., Ueda, K., Kioka, N., Komano, T., Hori, R. (1992) Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J. Pharmacol. Exp. Ther. 263: 840-845
29. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., Willigham, M. C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84: 7735-7738
30. Ueda, K., Yoshida, A., Amachi, T. (1999) Recent progress in P-glycoprotein research. Anticancer Drug Des. 14: 115-121
31. Yeh, J. Y., Huang, W. J., Kan, S. F., Wang, P. S. (2001) Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells. J. Urol. 166: 1937-1942